Medicare to broaden coverage of Alzheimer’s drugs after full FDA approval, but with some restrictions
Fierce Healthcare
JUNE 1, 2023
The Centers for Medicare and Medicaid Services outlined plans Thursday to broadly cover a new class of Alzheimer’s drugs once the medications get full approval from the Food and Drug Administration | CMS outlined plans Thursday to broadly cover a new class of Alzheimer’s drugs once the medications get full approval from the Food and Drug Administration.
Let's personalize your content